Measurement of SC5b-9 in urine in patients with the nephrotic syndrome

Kidney International - Tập 40 Số 6 - Trang 1141-1147 - 1991
James L. Ogrodowski1, Lee A. Hebert2, Daniel D. Sedmak, Fernando G. Cosio3, John D. Tamerius, William P. Kolb
1Department of Internal Medicine, Ohio State University, Columbus
2The Quidel Corporation, La Jolla, California, USA
3Nephrology and Hypertension

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pruchno, 1989, Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis, Kidney Int, 36, 65, 10.1038/ki.1989.162

Kerjaschki, 1989, Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy, J Immunol, 143, 546

Schulze, 1989, Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat, Kidney Int, 35, 60, 10.1038/ki.1989.8

Pruchno, 1991, Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis, Am J Pathol, 138, 203

Coupes, 1990, Urinary MAC and C3dg levels in human membranous nephropathy (HMN). Evidence for site of activation and clinical correlation, 2

Gordon, 1985, Amida-tion of C3 at the thiolester site: Stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator, J Immunol, 134, 3339

Hostetter, 1989, The erythrocyte as instigator of inflammation, J Clin Invest, 84, 665, 10.1172/JCI114213

Sharma, 1989, An improved immu-noperoxidase technique using horseradish peroxidase avidin D, Lab Med, 20, 109, 10.1093/labmed/20.2.109

Cattran, 1989, A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy, N Engl J Med, 320, 210, 10.1056/NEJM198901263200403

West, 1987, A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis, Kidney Int, 32, 579, 10.1038/ki.1987.247

Ponticelli, 1989, A randomized trial of methylprednis-olone and chlorambucil in idiopathic membranous nephropathy, N Engl J Med, 320, 8, 10.1056/NEJM198901053200102

Camussi, 1985, In vivo localization of C3 on the brush border of proximal tubules of kidneys from nephrotic patients, Clin Nephrol, 23, 134

Eddy, 1989, Interstitial nephritis induced by protein-overload proteinuria, Am J Pathol, 135, 719

Alfrey, 1990, Renal iron handling in the nephrotic syndrome, Kidney Int, 37, 1409, 10.1038/ki.1990.130

Mori, 1986, Proteinuria induced by transplantable rat pituitary tumor MtT SA5, Lab Invest, 54, 636

Eddy, 1991, A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome, Am J Pathol, 148, 1111

Baker, 1984, Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases, J Immunol, 133, 877, 10.4049/jimmunol.133.2.877

Camussi, 1982, In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney, J Immunol, 128, 1659, 10.4049/jimmunol.128.4.1659

Caldwell, 1981, Lung injury induced by antibody fragments to angiotensin-converting enzyme, Am Assoc Pathol, 105, 54

Schulz, 1988, Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney, Lab Invest, 59, 789

Mendrick, 1980, Antibody-mediated injury to proximal tubules in Heymann nephritis, Kidney Int, 18, 328, 10.1038/ki.1980.143

Noble, 1981, Antibody-mediated injury to proximal tubules in the rat kidney induced by passive transfer of homologous anti-brush border serum, Clin Immunol Immunopathol, 19, 289, 10.1016/0090-1229(81)90071-4

Noble, 1983, Passively transferred anti-brush border antibodies induce injury of proximal tubules in the absence of complement, Clin Exp Immunol, 56, 281

Sato, 1974, Serum-induced inhibition of isotonic fluid absorption by the kidney proximal tubule, Biochim Biophys Acta, 354, 182, 10.1016/0304-4165(74)90004-X

Brunkhorst, 1990, Reduction of urinary C5b-9 excretion indicates response to therapy in membranous nephropathy (MN), 2